SK5512002A3 - Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions - Google Patents

Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions Download PDF

Info

Publication number
SK5512002A3
SK5512002A3 SK551-2002A SK5512002A SK5512002A3 SK 5512002 A3 SK5512002 A3 SK 5512002A3 SK 5512002 A SK5512002 A SK 5512002A SK 5512002 A3 SK5512002 A3 SK 5512002A3
Authority
SK
Slovakia
Prior art keywords
medicament
formula
treatment
compound
manufacture
Prior art date
Application number
SK551-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Andreas Weichert
Udo Albus
Hans-Willi Jansen
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of SK5512002A3 publication Critical patent/SK5512002A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK551-2002A 1999-10-27 2000-10-14 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions SK5512002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19951701A DE19951701A1 (de) 1999-10-27 1999-10-27 Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten
PCT/EP2000/010126 WO2001030327A2 (de) 1999-10-27 2000-10-14 Verwendung von 2-imidazolyl-substituierten carbinolen zur herstellung eines medikaments zur behandlung oder prophylaxe von durch ischämischen zuständen

Publications (1)

Publication Number Publication Date
SK5512002A3 true SK5512002A3 (en) 2002-08-06

Family

ID=7927020

Family Applications (1)

Application Number Title Priority Date Filing Date
SK551-2002A SK5512002A3 (en) 1999-10-27 2000-10-14 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions

Country Status (30)

Country Link
US (1) US6291502B1 (cg-RX-API-DMAC7.html)
EP (1) EP1227811B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003512419A (cg-RX-API-DMAC7.html)
KR (1) KR20020060213A (cg-RX-API-DMAC7.html)
CN (1) CN1188125C (cg-RX-API-DMAC7.html)
AR (1) AR026241A1 (cg-RX-API-DMAC7.html)
AT (1) ATE257702T1 (cg-RX-API-DMAC7.html)
AU (1) AU778836B2 (cg-RX-API-DMAC7.html)
BR (1) BR0015024A (cg-RX-API-DMAC7.html)
CA (1) CA2388956A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ295925B6 (cg-RX-API-DMAC7.html)
DE (2) DE19951701A1 (cg-RX-API-DMAC7.html)
DK (1) DK1227811T3 (cg-RX-API-DMAC7.html)
EE (1) EE200200218A (cg-RX-API-DMAC7.html)
ES (1) ES2213621T3 (cg-RX-API-DMAC7.html)
HK (1) HK1048938B (cg-RX-API-DMAC7.html)
HR (1) HRP20020362A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0203213A3 (cg-RX-API-DMAC7.html)
IL (1) IL149208A0 (cg-RX-API-DMAC7.html)
NO (1) NO20021909L (cg-RX-API-DMAC7.html)
NZ (1) NZ518586A (cg-RX-API-DMAC7.html)
PL (1) PL355911A1 (cg-RX-API-DMAC7.html)
PT (1) PT1227811E (cg-RX-API-DMAC7.html)
RU (1) RU2257205C2 (cg-RX-API-DMAC7.html)
SK (1) SK5512002A3 (cg-RX-API-DMAC7.html)
TR (1) TR200201140T2 (cg-RX-API-DMAC7.html)
TW (1) TWI246424B (cg-RX-API-DMAC7.html)
WO (1) WO2001030327A2 (cg-RX-API-DMAC7.html)
YU (1) YU20902A (cg-RX-API-DMAC7.html)
ZA (1) ZA200203035B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726829B2 (en) * 1997-04-08 2004-04-27 Scimed Life Systems, Inc. Method of manufacturing a stent
ATE400551T1 (de) 2002-01-04 2008-07-15 Neurosearch As Kaliumkanal-modulatoren
AR049847A1 (es) * 2004-07-29 2006-09-06 Merck & Co Inc Inhibidores de los canales de potasio
RU2373934C1 (ru) * 2008-03-19 2009-11-27 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
US10040767B2 (en) 2014-05-15 2018-08-07 Peloton Therapeutics, Inc. Benzimidazole derivatives and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
BE794940A (fr) * 1972-02-04 1973-08-02 Gist Brocades Nv Nouveaux composes anorexigenes
US4152441A (en) 1972-02-04 1979-05-01 Gist-Brocades N.V. Analgesic imidazolemethanols
US5063220A (en) * 1988-10-21 1991-11-05 Syntex Pharmaceuticals, Ltd. Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US6175013B1 (en) * 1994-06-10 2001-01-16 Eli Lilly And Company Imidazolinyl tachykinin receptor antagonists
DE69717627T2 (de) 1996-06-27 2003-09-18 Janssen Pharmaceutica N.V., Beerse N-4-(heteroarylmethyl)phenyl-heteroarylaminderivate

Also Published As

Publication number Publication date
AU1138201A (en) 2001-05-08
US6291502B1 (en) 2001-09-18
NO20021909D0 (no) 2002-04-23
HUP0203213A2 (en) 2003-05-28
DE50005040D1 (de) 2004-02-19
HK1048938A1 (en) 2003-04-25
TR200201140T2 (tr) 2002-11-21
EE200200218A (et) 2003-06-16
ATE257702T1 (de) 2004-01-15
TWI246424B (en) 2006-01-01
WO2001030327A3 (de) 2002-03-14
RU2002113666A (ru) 2004-01-10
DE19951701A1 (de) 2001-05-03
DK1227811T3 (da) 2004-04-19
CZ295925B6 (cs) 2005-11-16
AR026241A1 (es) 2003-02-05
HRP20020362A2 (en) 2004-02-29
HK1048938B (zh) 2005-06-10
EP1227811A2 (de) 2002-08-07
NZ518586A (en) 2004-07-30
JP2003512419A (ja) 2003-04-02
CA2388956A1 (en) 2001-05-03
CZ20021452A3 (cs) 2002-07-17
ES2213621T3 (es) 2004-09-01
CN1373663A (zh) 2002-10-09
WO2001030327A2 (de) 2001-05-03
PL355911A1 (en) 2004-05-31
YU20902A (sh) 2004-11-25
RU2257205C2 (ru) 2005-07-27
KR20020060213A (ko) 2002-07-16
EP1227811B1 (de) 2004-01-14
BR0015024A (pt) 2002-06-18
AU778836B2 (en) 2004-12-23
HUP0203213A3 (en) 2003-07-28
CN1188125C (zh) 2005-02-09
NO20021909L (no) 2002-04-23
IL149208A0 (en) 2002-11-10
PT1227811E (pt) 2004-05-31
ZA200203035B (en) 2003-03-14

Similar Documents

Publication Publication Date Title
US5428051A (en) Methods of combating pneumocystis carinii pneumonia and compounds useful therefor
CZ403392A3 (en) Amino-substituted benzylguanidines, process of their preparation, their use as medicaments and a medicament containing thereof
CZ290811B6 (cs) Substituované sulfonimidamidy, způsob jejich přípravy, jejich pouľití jako léčiva nebo diagnostika, jakoľ i léčivo, které je obsahuje
SK281527B6 (sk) Guanididy alkenylkarboxylových kyselín substituovaných fluórfenylovými skupinami, spôsob ich prípravy, ich použitie a liečivo, ktoré ich obsahuje
DE69327153T2 (de) Anti-hiv-medikament
SK5512002A3 (en) Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions
RU2165412C2 (ru) Бензоилгуанидины, способ их получения, способ ингибирования, фармацевтический состав и способ его получения
NL8101987A (nl) De verbinding 4-amino-1-beta-d-ribofuranosyl-1h-imidazo/4.5-c/-pyridine of een farmaceutisch aanvaardbaar zuuradditiezout daarvan; farmaceutisch preparaat.
SK5582002A3 (en) A medicament for treating or preventing diseases caused by ischaemic conditions
JPH11310538A (ja) 白血球の粘着または凝集抑制剤
US20220031690A1 (en) Anti-neurodegenerative disease agent
WO1996022096A1 (en) Pharmaceutical compositions containing bisaramil inhibiting radical production and process for preparing same
HK1050480B (en) Use of 2-amino-3, 4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions